FDA Product Code OCC: Respiratory Virus Panel Nucleic Acid Assay System
Under FDA product code OCC, respiratory virus panel nucleic acid assay systems are cleared for multiplex detection of respiratory viral pathogens.
These assays simultaneously identify multiple common respiratory viruses — including influenza A/B, RSV, parainfluenza, adenovirus, and human metapneumovirus — from a single respiratory specimen, enabling rapid and comprehensive viral diagnosis for patient cohorting and treatment decisions.
OCC devices are Class II medical devices, regulated under 21 CFR 866.3980 and reviewed by the FDA Microbiology panel.
Leading manufacturers include Cepheid, Roche Molecular Systems, Inc. and Hologic, Inc..
79
Total
78
Cleared
97d
Avg days
2008
Since
79 devices
Cleared
Dec 03, 2015
Xpert Flu+RSV Xpress, Xpert Nasopharyngeal Sample Collection Kit, GeneXpert Xpress System (GX-I)
Cepheid
Microbiology
210d
Cleared
Nov 20, 2015
ProFlu+ Assay
Hologic, Inc.
Microbiology
15d
Cleared
Nov 22, 2014
XPERT FLU/RSV XC ASSAY
Cepheid
Microbiology
117d
Cleared
Oct 09, 2014
LYRA ADENOVIRUS ASSAY
Quidel Corporation
Microbiology
85d
Cleared
Sep 06, 2013
QUIDEL MOLECULAR RSV + HMPV ASSAY
Quidel Corp.
Microbiology
78d
Cleared
Dec 21, 2012
ABBOTT PLEX-ID FLU ASSAY
Abbott Laboratories
Microbiology
263d
Cleared
Dec 21, 2012
XPERT FLU
Cepheid
Microbiology
71d
Cleared
Dec 22, 2011
QUIDEL MOLECULAR INFLUENZA A + B ASSAY
Quidel Corp.
Microbiology
147d